JOHN HOFFSTETTER: Open Payments
NPI 1366454951 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,204 in 121 payments from 16 companies in 2025. Trend: 2023 $1,888 · 2024 $1,866 · 2025 $2,204
Food & beverage: $2,109Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $435 |
| ABBVIE INC. | 22 | $303 |
| GENZYME CORPORATION | 7 | $234 |
| Regeneron Healthcare Solutions, Inc. | 7 | $232 |
| PFIZER INC. | 9 | $194 |
| Galderma Laboratories, L.P. | 12 | $178 |
| Arcutis Biotherapeutics, Inc. | 16 | $173 |
| Incyte Corporation | 6 | $132 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| UCB, Inc. | 2 | $71 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Zoryve, NEMLUVIO, OPZELURA, LITFULO, RINVOQ.
Industry payments across FL — which companies pay providers there.
